| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 7786* | 2017 |
| Modified disease activity scores that include twenty‐eight‐joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis MLL Prevoo, MA Van'T Hof, HH Kuper, MA Van Leeuwen, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1995 | 7397 | 1995 |
| Genetics of rheumatoid arthritis contributes to biology and drug discovery Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ... Nature 506 (7488), 376-381, 2014 | 2480 | 2014 |
| Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of … AM Van Gestel, MLL Prevoo, MA Van't Hof, MH Van Rijswijk, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1996 | 1980 | 1996 |
| Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci EA Stahl, S Raychaudhuri, EF Remmers, G Xie, S Eyre, BP Thomson, Y Li, ... Nature genetics 42 (6), 508-514, 2010 | 1572 | 2010 |
| Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. DMFM van der Heijde, MA van't Hof, PL Van Riel, LA Theunisse, ... Annals of the rheumatic diseases 49 (11), 916-920, 1990 | 1391 | 1990 |
| A simplified disease activity index for rheumatoid arthritis for use in clinical practice JS Smolen, FC Breedveld, MH Schiff, JR Kalden, P Emery, G Eberl, ... Rheumatology 42 (2), 244-257, 2003 | 1316 | 2003 |
| The prognostic value of anti–cyclic citrullinated peptide antibody in patients with recent‐onset rheumatoid arthritis EJJA Kroot, BAW De Jong, MA Van Leeuwen, H Swinkels, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 1115 | 2000 |
| Development of a disease activity score based on judgment in clinical practice by rheumatologists. DM Van der Heijde, M Van't Hof, PL Van Riel, LB Van de Putte The Journal of rheumatology 20 (3), 579-581, 1993 | 1079 | 1993 |
| Validation of rheumatoid arthritis improvement criteria that include simplified joint counts AM van Gestel, CJ Haagsma, PLCM van Riel Arthritis & Rheumatism: Official Journal of the American College of …, 1998 | 1005 | 1998 |
| EULAR recommendations for the management of Behçet disease G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ... Annals of the rheumatic diseases 67 (12), 1656-1662, 2008 | 1001 | 2008 |
| The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk C Popa, MG Netea, PLCM Van Riel, JWM Van Der Meer, AFH Stalenhoef Journal of lipid research 48 (4), 751-762, 2007 | 976 | 2007 |
| Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in … G Wells, JC Becker, J Teng, M Dougados, M Schiff, J Smolen, D Aletaha, ... Annals of the rheumatic diseases 68 (6), 954-960, 2009 | 918 | 2009 |
| The Disease Activity Score and the EULAR response criteria J Fransen, P Van Riel Clinical and experimental rheumatology 23 (5), S93, 2005 | 897 | 2005 |
| Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system MCW Creemers, M Franssen, MA Van’t Hof, FWJ Gribnau, ... Annals of the rheumatic diseases 64 (1), 127-129, 2005 | 874 | 2005 |
| Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed LBA Van de Putte, C Atkins, M Malaise, J Sany, AS Russell, P Van Riel, ... Annals of the rheumatic diseases 63 (5), 508-516, 2004 | 783 | 2004 |
| Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis DM Van Der Heijde, PL Van Riel, FW Gribnau, IH Nuver-Zwart, ... The Lancet 333 (8646), 1036-1038, 1989 | 736 | 1989 |
| Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology F Buttgereit, JAP Da Silva, M Boers, GR Burmester, M Cutolo, J Jacobs, ... Annals of the rheumatic diseases 61 (8), 718-722, 2002 | 665 | 2002 |
| The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis PMJ Welsing, AM Van Gestel, HL Swinkels, LALM Kiemeney, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 653 | 2001 |
| Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria J Fransen, MCW Creemers, P Van Riel Rheumatology 43 (10), 1252-1255, 2004 | 626 | 2004 |
Timothy RadstakeHead Early Immunology Discovery Research, Abbvie在 abbvie.com 的电子邮件经过验证
